<p>McKesson Corporation has completed the sale of its retail and distribution businesses in Norway to NorgesGruppen, a privately owned retail group. This move marks the company’s final step in fully exiting its European operations and allows McKesson to focus on expanding its growth platforms in Oncology, Multispecialty, and Biopharma Services. Further details about the divestiture will be provided during the company’s upcoming Fiscal Third Quarter Earnings call and on its Investor Relations website. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. McKesson Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20260129535115) on January 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)</p>

159883

Reuters

iShares US Medical Devices

VanEck Pharmaceutical ETF

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

Direxion S&P Biotech Bull 3X

iShares US Pharma

GF CSI All Share Health Care ETF

SPDR Pharmac

Invesco Biotechnology & Genome ETF

Proshares UltraShort Nasdaq Biotech

China Merchants CSI All Share Medical Apparatus and Instruments ETF

Direxion S&P Biotech Bear 3X

SPDR S&P Biotech

VanEck Biotech ETF

ChinaAMC SSE Health Care ETF Initiating Fund

SPDR S&P Health Equip

First Trust NYSE Arca Biotech Index Fd

E Fund CSI 300 Health Care ETF

ALPS Medical Breakthrough

iShares Biotechnology ETF

Invesco Pharmaceuticals ETF

Proshares Ultra Nasdaq Biotech

ChinaAMC CSI All Share Health Care Devices ETF

China Universal 800 Health Care ETF

McKesson Completes Sale of Norwegian Businesses to NorgesGruppen